Jason Collins, whose NBA career spanned 13 years and six different teams, announced on Thursday that he has Stage 4 brain cancer. Specifically Collins has glioblastoma, a common form of brain cancer ...

Jason Collins, the NBA's first openly gay player, announced Thursday he has Stage 4 glioblastoma, an aggressive and deadly form of brain cancer. He expounded on the diagnosis and shared how he's ...

Former NBA player Jason Collins has Stage 4 glioblastoma. Collins — who in 2013 became the first openly gay active player in a men's North American sports league — revealed his diagnosis to ESPN's ...

Huntsman Cancer Institute at the University of Utah (the U) participated in a clinical trial that found that a new combination treatment plan helped people with recurring grade 3 astrocytoma, an ...

Imvax has shrugged off the failure of its phase 2b brain cancer trial to hit its primary endpoint, reporting evidence of improved overall survival (OS) and making a beeline for the FDA. The study ...

Patients who received a focused ultrasound treatment to aid drug delivery increased their odds of surviving the deadliest form of brain cancer by nearly 40%, according to a study led by University of ...

A mom was diagnosed with brain cancer after the tingling in her arm was dismissed as anxiety. Kelsey Stokstad, 32, started experiencing numbness and tingling in her left arm and hand but doctors told ...

The nanomaterial (red) that travels along a nerve (green) from the nose to the brain, where it triggers an immune response to eliminate the tumor. Credit: Alexander Stegh Researchers at Washington ...

Nasal drops may offer a new non-invasive way to help the body fight aggressive and deadly brain cancers. Researchers at Washington University School of Medicine and Northwestern University have ...

A new nasal-delivered nanotherapy shows promise against aggressive glioblastoma tumors. By activating the STING immune pathway using gold-core spherical nucleic acids, researchers were able to reach ...

Amgad M, Salgado R, Cooper LA. A panoptic segmentation approach for tumor-infiltrating lymphocyte assessment: development of the MuTILs model and PanopTILs dataset. medRxiv 2022.01.08.22268814.